Why Should You Attend:
This course will cover the newly proposed requirements for conducting clinical studies across the EU via the requirements of the EU Clinical Trial Regulation 536/2014 (for drugs, biologics and combination products). The course will also cover recent updates on EU-GCP associated with the directive, the highlights of the new EU pharmacovigilance directive, as it relates to studies and helpful tips into working with European regulators.
This new regulation will affect all sponsors of clinical studies conducted in the EU. Changes against the current EU Clinical Trial Directive 2001/20/EC will be highlighted in the webinar. This new regulation is expected to go into force in the EU no earlier than May 2016. Knowing what changes will be implemented now will allow all sponsors time to adjust their processes and responsibilities across the EU.
Attendees will leave the Course clearly understanding the New Processes and Requirements for EU Sponsors of Clinical Trials as the New Regulation is published, rolled-out and implemented by the Member States, the European Medicines Agency and the European Commission. In addition, this Course has been updated to provide participants with competitive insight into:
Areas Covered in the Webinar:
Who Will Benefit:
This 90-minute overview will be of value to clinical research professionals, project team members and associated disciplines conducting clinical studies across the European Union. The course will benefit the following personnel:
For the past 9 years, Robert J. Russell has been the president of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with international regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington DC, and Brussels, Belgium with exclusive affiliates across Asia and Latin America. Mr. Russell has 28 years of past industry experience as a CMC specialist, R&D director and global director of regulatory affairs for Merion Merrill Dow Pharmaceuticals and Cordis-Dow Medical Devices. He has a BS and MS degree in chemistry.
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
PAYMENT METHOD: 100% Secure Transaction